FDAAA and the Office of New Drugs: An Interview with Dr. John Jenkins.

| 01 May 2009

On 5 March, Dr. John Jenkins, director of the US Food and Drug Administration's Office of New Drugs, took the time to answer some questions on the Food and Drug Administration Amendments Act posed by the RAPS Board of Editors.

 

© 2022 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy